OB/GYN Clinical Alert (Vol. 32, No. 2)

Read the Disclosure Information Below, then click “Continue” to begin testing.

Release date: June 2015

Valid through: June 2018

Target Audience

This activity is intended for the obstetrician and gynecologist.

Subjects

Isotretinoin and Contraception: Should iPLEDGE Be Changed?
Are We Ready to Give Up the Pap Smear?
Mammograms: The Cost of Overdiagnosis
Special Feature: Macrosomia

Objectives

Explain the latest data regarding diagnosis and treatment of various diseases affecting women
Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women

Credit Available

Physicians

Maximum of 2.25 AMA PRA Category 1 Credit(s)™

Sponsor

This activity is sponsored by AHC Media.

Accreditation Statement

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation

Physicians

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty Listing

Authors

Rebecca H. Allen, MD, MPH, Assistant Professor, Department of Obstetrics and Gynecology, Warren Alpert Medical School of Brown University, Women and Infants Hospital, Providence, RI

Molly A. Brewer, DVM, MD, MS, Professor and Chair, Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, Carole and Ray Neag Comprehensive Cancer Center, University of Connecticut Health Center, Farmington

Jeffrey T. Jensen, MD, MPH, Leon Speroff Professor and Vice Chair for Research, Department of Obstetrics and Gynecology, Oregon Health & Science University, Portland

John C. Hobbins, MD, Professor, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora

Editors

Medical Editor: Jeffrey T. Jensen, MD, MPH

AHC Media executive editor: Leslie G. Coplin

Associate managing editor: Jonathan Springston

Financial Disclosure

Rebecca Allen, MD, reports she is a consultant for Actavis and Bayer and receives grant/research support from Bayer. Molly A. Brewer, MD, reports she receives grant support from the National Cancer Institute. John C. Hobbins, MD, reports no financial relationships relevant to this field of study.

OB/GYN Clinical Alert's Editor, Jeffrey T. Jensen, MD, MPH, is a consultant for and receives grant/research support from HRA Pharma, Bayer Healthcare, Merck, Agile Pharm, Population Council, AbbVie, Evofem and ContraMed; and is a consultant for Teva Pharmaceuticals and MicroChips.

Peer Reviewer Catherine LeClair, MD, Executive Editor Leslie G. Coplin, and Associate Managing Editor Jonathan Springston report no financial relationship to this field of study.

OB/GYN Clinical Alert (Vol. 32, No. 2) – June 1, 2015